Amazing results confirming our ambition

Updated: Dec 10, 2018

We are currently testing our solution in the field of diabetology with doctors from some of the top hospitals in Europe and our current results show that RAMP increases the rate of finding the optimal therapy close to 100% and decreases the rate of decision mistakes close to 0%.

Quality of the therapy decision made by doctors with and without RAMP

​We are open to more clinics and practices participating in our pilot study. To participate, please contact our CSO Jacques Ehret.

We are looking for €1.5M investment for 2019:

€500K - finalize development medical field pain medicine beta, cardiology beta & medical device certification

€500K - strengthen tech infrastructure, development medical fields infectiology beta & oncology beta

€500K - go to market We are looking for public funding, early stage VC and angel investments.

For more investment information, please contact our CEO Helene Schönewolf.


Henisaja GmbH


Kastanienallee 61

10119 Berlin


Chief Executive Officer:  Helene Schönewolf

+49 (0) 30 31 98 08 52​

Registered at the local court Berlin Charlottenburg HRB 167143 B

VAT: DE299921795

Follow us


Copyright 2020 | RAMPmedical